Growth Metrics

Cytosorbents (CTSO) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.39%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.38%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 6.53%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 11.20%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.20%
Dec 31, 2025 -92.87%
Sep 30, 2025 36.19%
Jun 30, 2025 29.64%
Mar 31, 2025 45.16%
Dec 31, 2024 6.67%
Sep 30, 2024 24.40%
Jun 30, 2024 2.81%
Mar 31, 2024 -13.47%
Dec 31, 2023 190.96%
Sep 30, 2023 -122.05%
Jun 30, 2023 -28.99%
Mar 31, 2023 -28.50%
Dec 31, 2022 42.11%
Sep 30, 2022 -21.01%
Jun 30, 2022 -45.29%
Mar 31, 2022 -22.45%
Dec 31, 2021 -19.87%
Sep 30, 2021 -28.71%
Jun 30, 2021 7.03%
Mar 31, 2021 -11.81%
Dec 31, 2020 40.06%
Sep 30, 2020 25.78%
Jun 30, 2020 -18.23%
Mar 31, 2020 -31.31%
Dec 31, 2019 6.98%
Sep 30, 2019 -46.54%
Jun 30, 2019 -5.68%
Mar 31, 2019 -38.55%
Dec 31, 2018 -17.31%
Sep 30, 2018 -1.81%
Jun 30, 2018 -82.30%
Mar 31, 2018 14.17%
Dec 31, 2017 14.27%
Sep 30, 2017 -11.09%
Jun 30, 2017 2.19%
Mar 31, 2017 -16.07%
Dec 31, 2016 -94.28%
Sep 30, 2016 -31.39%
Jun 30, 2016 -28.54%
Mar 31, 2016 -4.07%
Dec 31, 2015 -83.96%
Sep 30, 2015 -63.46%
Jun 30, 2015 49.92%
Mar 31, 2015 -48.98%
Dec 31, 2014 -60.99%
Sep 30, 2014 4.66%
Jun 30, 2014 -11.39%
Mar 31, 2014 7.06%
Dec 31, 2013 -12.09%
Sep 30, 2013 -6.96%
Jun 30, 2013 -27.90%